World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
28364
World Ranking
13164
National Ranking
542

Overview

Jay S. Wunder is affiliated with the University of Toronto in Canada. Their primary research focus lies within the field of Medicine, with a significant concentration on subfields such as Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Oncology, and Cancer Research.

The scientist's work addresses several main topics in medical research, notably Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Vascular Tumors and Angiosarcomas, Musculoskeletal synovial abnormalities and treatments, Management of metastatic bone disease, Cancer Genomics and Diagnostics, and Tumors and Oncological Cases.

Among their recent publications are the following papers:

  • Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors, 2022, JAMA Oncology
  • Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet, 2020, Cancer
  • Immuno-transcriptomic profiling of extracranial pediatric solid malignancies, 2021, Cell Reports
  • H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone, 2020, Cancer Discovery
  • Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival, 2021, Nature Communications

Their frequent co-authors include:

  • Peter C. Ferguson
  • Anthony M. Griffin
  • Kim M. Tsoi
  • Irene L. Andrulis
  • Nalan Gökgöz

Jay S. Wunder commonly publishes in a number of established venues, such as:

  • Annals of Surgical Oncology
  • The Bone & Joint Journal
  • Cancer Research
  • Journal of Surgical Oncology
  • Journal of Clinical Oncology

Best Publications

  • Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

    Brian O'Sullivan;Aileen M Davis;Robert Turcotte;Robert Turcotte;Robert Bell;Robert Bell

  • Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

    K. E. Noonan;C. Beck;T. A. Holzmayer;J. E. Chin

  • Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma

    Aileen M. Davis;Aileen M. Davis;Brian O'Sullivan;Robert Turcotte;Robert Bell;Robert Bell

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Kevin B. Jacobs;Meredith Yeager;Meredith Yeager;Weiyin Zhou;Weiyin Zhou;Sholom Wacholder

  • EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

    E. De Alava;A. Kawai;J. H. Healey;I. Fligman

  • Treatment of giant-cell tumors of long bones with curettage and bone-grafting.

    H. R. Blackley;J. S. Wunder;A. M. Davis;L. M. White

  • Giant cell tumor of long bone: a Canadian Sarcoma Group study.

    Robert E. Turcotte;Jay S. Wunder;Marc H. Isler;Robert S. Bell

  • Chordoma: long-term follow-up after radical photon irradiation

    Charles Catton;Brian O'Sullivan;Robert Bell;Normand Laperriere

  • Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

    Dario Callegaro;Rosalba Miceli;Sylvie Bonvalot;Peter Ferguson

  • Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape

    Chao Lu;Siddhant U. Jain;Dominik Hoelper;Denise Bechet

  • Predominance of Beta-Catenin Mutations and Beta-Catenin Dysregulation in Sporadic Aggressive Fibromatosis (Desmoid Tumor)

    Sabine Tejpar;Friedel Nollet;Catherine Li;Jay S Wunder

  • Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence

    C. H. Gerrand;J. S. Wunder;R. A. Kandel;B. O’Sullivan

  • Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.

    Sabrena Noria;Aileen Davis;Rita Kandel;Jerome Levesque

  • Side population cells isolated from mesenchymal neoplasms have tumor initiating potential.

    Colleen Wu;Qingxia Wei;Velani Utomo;Puviindran Nadesan

  • Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma

    Aileen M. Davis;B. O'Sullivan;R. S. Bell;R. Turcotte

  • Cartilage tumours and bone development: molecular pathology and possible therapeutic targets

    Judith V. M. G. Bovée;Pancras C. W. Hogendoorn;Jay S. Wunder;Benjamin A. Alman

  • A mutant PTH/PTHrP type I receptor in enchondromatosis

    Sevan Hopyan;Nalan Gokgoz;Raymond Poon;Robert C. Gensure

  • The Histological Response to Chemotherapy as a Predictor of the Oncological Outcome of Operative Treatment of Ewing Sarcoma

    Jay S. Wunder;Gabe Paulian;Andrew G. Huvos;Glenn Heller

  • Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma.

    Brian O'Sullivan;Anthony M. Griffin;Colleen I. Dickie;Michael B. Sharpe

  • Detectable clonal mosaicism and its relationship to aging and cancer

    Kevin B. Jacobs;Meredith Yeager;Weiyin Zhou;Sholom Wacholder

Frequent Co-Authors

Brian O'Sullivan
Brian O'Sullivan Princess Margaret Cancer Centre
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Charles Catton
Charles Catton University of Toronto
Aileen M. Davis
Aileen M. Davis University of Toronto
Benjamin A. Alman
Benjamin A. Alman Duke University
Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
Adrienne M. Flanagan
Adrienne M. Flanagan University College London
Meredith Yeager
Meredith Yeager Hood College
Sharon A. Savage
Sharon A. Savage National Institutes of Health
Lisa Mirabello
Lisa Mirabello National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a future in healthcare, there are several flexible and affordable online degree pathways that can complement or lead to medical studies in the USA. One popular option is nursing, with many programs tailored for different backgrounds and goals.

If you already have a nursing license and are seeking an advanced degree, you might explore the cheapest dnp online program options. These programs can lead to advanced clinical or leadership roles while keeping education costs manageable.

Those holding an RN license may want to finish their bachelor’s degree through one of the cheapest rn to bsn online programs, which provide a cost-effective and flexible path to career advancement.

Non-nursing majors who wish to switch careers can benefit from direct entry msn programs for non-nursing majors online. These accelerated degrees help students with non-nursing backgrounds obtain advanced clinical skills faster.

Finally, students looking for accessible options should review the easiest nursing programs to get into, which may offer lower barriers for entry while still preparing you for a rewarding healthcare career.

Best Scientists Citing Jay S. Wunder

Trending Scientists